d-alpha tocopherol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (52.94) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 1 (5.88) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Heikkila, RE; Sieber, BA; Terleckyj, I | 1 |
Cadet, JL | 1 |
Bergeron, C; Foulks, JG; Hansen, S; Jones, K; Perry, TL; Wright, JM; Yong, VW | 1 |
Di Monte, D; Sandy, MS; Smith, MT | 1 |
Hirai, S | 1 |
Cohen, P; Di Monte, D; Sandy, MS; Smith, MT | 1 |
Krisman, AA; Perry, TL; Yong, VW | 1 |
Cohen, O; Martinovits, G; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
Angelucci, L; Fariello, RG; Ghirardi, O; Peschechera, A; Ramacci, MT | 1 |
Clavier, RM; Foulks, JG; Jones, K; Perry, TL; Wall, RA; Wright, JM; Yong, VW | 1 |
Andersen, JK; Jurma, OP; Wei, Q; Yeung, M | 1 |
Jiang, DH; Lan, J | 1 |
Selley, ML | 1 |
Cynshi, O; Itoh, N; Jishage, K; Masuo, Y; Niki, E; Yoshida, Y | 1 |
Jishage, K; Mizuno, Y; Mochizuki, H; Nishida, Y; Ren, YR; Uchihara, T; Yasuda, T; Yokota, T; Yoshimi, K | 1 |
Gómez-Rodríguez, VM; González-Renovato, ED; Ortiz, GG; Pacheco-Moisés, FP; Ramírez-Anguiano, AC; Torres-Sánchez, ED | 1 |
Ahmad, R; Ali, J; Atiq, A; Choe, K; Kang, MH; Khan, A; Kim, MO; Lee, HJ; Park, JS; Rehman, IU; Tahir, M | 1 |
1 review(s) available for d-alpha tocopherol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Corpus Striatum; Deferoxamine; Dopamine; Female; Glutathione; Glutathione Disulfide; Hydroxyl Radical; Iron; Lipid Peroxides; Male; Mice; Nerve Degeneration; Osmolar Concentration; Vitamin E | 1997 |
16 other study(ies) available for d-alpha tocopherol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biotransformation; Brain; Humans; In Vitro Techniques; Male; Mice; Monoamine Oxidase; Nervous System; Neurotoxins; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Inbred Strains; Selegiline; Vitamin E | 1990 |
The potential use of vitamin E and selenium in parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Humans; Hydroxydopamines; Neurons; Oxidopamine; Parkinson Disease; Pyridines; Rats; Selenium; Vitamin E | 1986 |
Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; beta Carotene; Brain; Callitrichinae; Carotenoids; Corpus Striatum; Dopamine; Drug Interactions; Male; Pyridines; Substantia Nigra; Vitamin E | 1987 |
Relationships between intracellular vitamin E, lipid peroxidation, and chemical toxicity in hepatocytes.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adenosine Diphosphate; Animals; Carmustine; Diquat; Dithiothreitol; Dose-Response Relationship, Drug; Glutathione; In Vitro Techniques; Lipid Peroxides; Liver; Male; Phenylenediamines; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Vitamin E | 1988 |
[Biochemistry of the physiopathologic and clinical aspects of free radicals in cerebral degenerative diseases such as Alzheimer's and Parkinson diseases].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Animals; Catecholamines; Free Radicals; Humans; Lipid Peroxides; Monoamine Oxidase; Parkinson Disease; Pyridines; Superoxide Dismutase; Vitamin E | 1988 |
Role of active oxygen in paraquat and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cytotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Carmustine; Cell Survival; Cells, Cultured; Deferoxamine; Free Radicals; Lipid Peroxidation; Liver; Paraquat; Phenylenediamines; Pyridines; Rats; Reference Values; Vitamin E | 1988 |
Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; beta Carotene; Brain Stem; Carotenoids; Corpus Striatum; Dopamine; Glutathione; Male; Mice; Mice, Inbred C57BL; Premedication; Pyridines; Substantia Nigra; Vitamin E | 1986 |
Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Ascorbic Acid; Brain Chemistry; Corpus Striatum; Dimethyl Sulfoxide; Dopamine; Drug Administration Schedule; Drug Combinations; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Neurotoxins; Pyridines; Substantia Nigra; Vitamin E | 1986 |
Transient nigral ubiquinone depletion after single MPTP administration in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Female; Mice; Pyridines; Substantia Nigra; Ubiquinone; Vitamin E | 1987 |
Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Carotenoids; Corpus Striatum; Male; Mice; Mice, Inbred C57BL; Neural Pathways; Pyridines; Substantia Nigra; Vitamin E | 1985 |
Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Survival; Dopamine; Dopamine Agents; Free Radicals; Gene Expression Regulation, Enzymologic; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotoxins; PC12 Cells; Plasmids; Rats; Selegiline; Sensitivity and Specificity; Vitamin E | 1996 |
(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aldehydes; Animals; Brain Stem; Cross-Linking Reagents; Drug Administration Routes; Glutathione; Humans; Injections, Subcutaneous; Male; Mice; Middle Aged; Parkinson Disease; Substantia Nigra; Time Factors; Vitamin E | 1998 |
gamma-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than alpha-tocopherol in mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Tocopherol; Animals; Antioxidants; Brain; Dopamine; gamma-Tocopherol; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Vitamins | 2006 |
Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Brain; Corpus Striatum; Disease Susceptibility; Dopamine Antagonists; Genotype; Glutathione; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotoxins; Parkinsonian Disorders; Substantia Nigra; Superoxide Dismutase; Superoxide Dismutase-1; Vitamin E; Vitamin E Deficiency | 2006 |
Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cyclooxygenase 2; Fish Oils; Lipid Peroxidation; Melatonin; Mesencephalon; Mice; Mice, Inbred C57BL; Oxidative Stress; Vitamin E | 2013 |
Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Motor Disorders; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase; Vitamin E | 2023 |